BioNAV Hits New Milestone: Air Particle ID Process Patent Published on WIPO

Springfield, Missouri, December 26, 2024 – At BioNAV Health & Wellness, we are thrilled to announce a major milestone in our journey to revolutionize air quality analysis. Our innovative Air Particle ID process, protected under the international patent notice WO2024249697 recently published by WIPO (World Intellectual Property Organization), represents a groundbreaking leap in identifying and analyzing debris collected in air filtration systems. As part of the PCT patent process, the WIPO notice is now available to the public for interested strategic partners and manufacturers that produce airflow-based products.

Beyond Detection: Turning Data Into Actionable Insights

Our filtered debris classification process goes beyond simply analyzing particles. It enables our licensed clients to integrate identified air particulate data from various environments—collecting molds, pollen, and other filtered debris—where various environmental data is combined into an intuitive and personalized end-user mobile app. This creates a unified platform for monitoring and acting upon air quality insights. The benefits extend to multiple stakeholders, including:

1. Empowering End-Users (Patients) with Respiratory Conditions:

   • For individuals with asthma, allergies, or chronic respiratory diseases, the app offers a proactive way to control environmental exposures by enabling 3rd party app triggers and notifications via BioNAV's end-user mobile app.

   • This can help users make informed decisions about their surroundings, improving their quality of life.
     

2. Revolutionizing Personalized Treatment Tools for Pulmonologists:

   • Improve patient-to-doctor communications: Patients using our mobile app can proactively share their combined analyzed data collected from various environments with their healthcare providers. Examples include home HVAC systems, recycled cabin airflow in vehicles, and personal air-filtered devices.

   • By integrating detailed debris analysis into patient care, specialists gain access to new tools for early-stage diagnosing and treating respiratory conditions.

   • This data enables pulmonologists to potentially deliver tailored treatment plans, targeting specific indoor/outdoor environmental factors and extreme weather events.
     

3. Enabling Early Detection of Respiratory Diseases:

   • The technology allows specialists to analyze patterns and correlate environmental exposures with early indicators of respiratory diseases.

   • Our patient-to-doctor tool may also possibly help identify the onset of conditions like COPD or occupational asthma at earlier, more treatable stages.

Monetization Potential: Transforming Analyzed Data into New Strategic Revenue Growth

The commercialization opportunities for this technology are extensive. Key monetization avenues include:

• Integration with Consumer Products:  By subscribing to our annual license, manufacturers can add premium features to filtration systems, appealing to health-conscious consumers.

• Branded Subscription-Based Apps: Manufacturers can create a whole new recurring revenue strategy from end-users seeking branded analyzed data and recommendations.

• Healthcare Partnerships: Collaborate with pulmonologists and healthcare providers to establish new value-added data storage networks for patient care using analyzed environmental data.

• Enterprise Solutions: Provide businesses with tools to enhance workplace air quality, reduce sick days, and meet regulatory compliance.
  

A Paradigm Shift in Air Quality Management

By combining advanced imaging, AI-driven particle classification, and seamless data integration, this process delivers a comprehensive solution that connects users, healthcare professionals, and manufacturers. It bridges the gap between environmental monitoring and actionable health outcomes, unlocking new possibilities for personalized care and early disease detection.

Join the Movement for Cleaner Air and Better Health

BioNAV is seeking strategic partnerships with forward-thinking investors, healthcare organizations, AI/ML object recognition developers, and airflow-based product manufacturers to bring this technology to global markets. Let’s work together to redefine air quality standards and create a healthier, more sustainable future.

Industries that can benefit from using BioNAV's Air Particle ID technologies.

For inquiries contact us today at info@bionav.com. BioNAV®  is a registered U.S. Trademark. © 2024-2025. www.bionav.com.